A Wirth

Summary

Country: Germany

Publications

  1. ncbi request reprint Long-term weight loss with sibutramine: a randomized controlled trial
    A Wirth
    Teutoburger Wald Klinik, Teutoburger Wald Strasse 33, Bad Rothenfelde, 49214 Germany
    JAMA 286:1331-9. 2001
  2. doi request reprint [Anti-diabetic drugs. Weight reduction as a favourable side effect]
    A Wirth
    Internist (Berl) 52:451-2, 455-8, 460-1. 2011
  3. ncbi request reprint [Sustained weight reduction after cessation of obesity treatment with Sibutramine]
    A Wirth
    Teutoburger Wald Klinik, Bad Rothenfelde
    Dtsch Med Wochenschr 129:1002-5. 2004
  4. ncbi request reprint Reduced left ventricular mass after treatment of obese patients with sibutramine: An echocardiographic multicentre study
    A Wirth
    Teutoburger Wald Klinik, Bad Rothenfelde, Germany
    Diabetes Obes Metab 8:674-81. 2006
  5. ncbi request reprint [Hypertension and cardiomyopathy in obesity. Treat the heart simultaneously]
    A Wirth
    Teutoburger Wald Klinik, Bad Rothenfelde
    MMW Fortschr Med 143:39-42. 2001
  6. ncbi request reprint [Role of body weight for the prevention of coronary heart disease]
    A Wirth
    Teutoburger Wald Klinik, Teutoburger Wald Strasse 33, 49214 Bad Rothenfelde, Germany
    Z Kardiol 94:III/22-9. 2005
  7. ncbi request reprint [Metabolic syndrome and erectile dysfunction. Epidemiologic associations and pathogenetic links]
    A Wirth
    Teutoburger Wald Klinik, Teutoburger Wald Str 33, 49214, Bad Rothenfelde, Deutschland
    Urologe A 46:287-92. 2007
  8. ncbi request reprint [Weight loss via drug therapy]
    A Wirth
    Teutoburger Wald Klinik, Bad Rothenfelde
    Internist (Berl) 44:359-62, 363-6. 2003
  9. ncbi request reprint [Obesity treatment in specialized rehabilitation centers - the "Reha-Team" and process quality]
    A Römpler
    Teutoburger Wald Klinik, Bad Rothenfelde, Germany
    Z Gastroenterol 40:S18-S21. 2002

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Long-term weight loss with sibutramine: a randomized controlled trial
    A Wirth
    Teutoburger Wald Klinik, Teutoburger Wald Strasse 33, Bad Rothenfelde, 49214 Germany
    JAMA 286:1331-9. 2001
    ..Treatment of obesity requires long-term therapy, which can be hampered by difficulties in achieving patient compliance. The effectiveness of sibutramine hydrochloride in treating obesity has been shown in randomized controlled trials...
  2. doi request reprint [Anti-diabetic drugs. Weight reduction as a favourable side effect]
    A Wirth
    Internist (Berl) 52:451-2, 455-8, 460-1. 2011
    ..By using anti-diabetic drugs as monotherapy or in combination with other anti-diabetic compounds body weight, glycemic control and other cardiovascular risk factors may be influenced favorably...
  3. ncbi request reprint [Sustained weight reduction after cessation of obesity treatment with Sibutramine]
    A Wirth
    Teutoburger Wald Klinik, Bad Rothenfelde
    Dtsch Med Wochenschr 129:1002-5. 2004
    ..Aim of the study was to examine the course of body weight and cardiovascular risk parameters under the everyday life conditions in general practice after obese patients had terminated their sibutramine treatment...
  4. ncbi request reprint Reduced left ventricular mass after treatment of obese patients with sibutramine: An echocardiographic multicentre study
    A Wirth
    Teutoburger Wald Klinik, Bad Rothenfelde, Germany
    Diabetes Obes Metab 8:674-81. 2006
    ..Following body weight reduction, the left ventricular mass (LVM) is reduced. It is not known to which extent this occurs after treatment with sibutramine...
  5. ncbi request reprint [Hypertension and cardiomyopathy in obesity. Treat the heart simultaneously]
    A Wirth
    Teutoburger Wald Klinik, Bad Rothenfelde
    MMW Fortschr Med 143:39-42. 2001
    ..In some cases, Sibutramine and Orlistat may have a supporting role. For the antihypertensive treatment of the obese, drugs with a favorable hemodynamic and metabolic effect should be used...
  6. ncbi request reprint [Role of body weight for the prevention of coronary heart disease]
    A Wirth
    Teutoburger Wald Klinik, Teutoburger Wald Strasse 33, 49214 Bad Rothenfelde, Germany
    Z Kardiol 94:III/22-9. 2005
    ..Effects on coronary atherosclerosis and congestive heart disease are until now insufficiently investigated...
  7. ncbi request reprint [Metabolic syndrome and erectile dysfunction. Epidemiologic associations and pathogenetic links]
    A Wirth
    Teutoburger Wald Klinik, Teutoburger Wald Str 33, 49214, Bad Rothenfelde, Deutschland
    Urologe A 46:287-92. 2007
    ....
  8. ncbi request reprint [Weight loss via drug therapy]
    A Wirth
    Teutoburger Wald Klinik, Bad Rothenfelde
    Internist (Berl) 44:359-62, 363-6. 2003
    ..Under the supervision of experienced physicians the combined treatment consisting of non-pharmacological and pharmacological methods reduces body weight in more than half of the patients and improves morbidity and quality of life...
  9. ncbi request reprint [Obesity treatment in specialized rehabilitation centers - the "Reha-Team" and process quality]
    A Römpler
    Teutoburger Wald Klinik, Bad Rothenfelde, Germany
    Z Gastroenterol 40:S18-S21. 2002
    ....